290 related articles for article (PubMed ID: 33329593)
41. Simultaneous quantification of natural and inducible regulatory T-cell subsets during interferon-β therapy of multiple sclerosis patients.
Chiarini M; Capra R; Serana F; Bertoli D; Sottini A; Giustini V; Scarpazza C; Rovaris M; Torri Clerici V; Ferraro D; Galgani S; Solaro C; Conti MZ; Visconti A; Imberti L;
J Transl Med; 2020 Apr; 18(1):169. PubMed ID: 32299447
[TBL] [Abstract][Full Text] [Related]
42. Induction of Proinflammatory Multiple Sclerosis-Associated Retrovirus Envelope Protein by Human Herpesvirus-6A and CD46 Receptor Engagement.
Charvet B; Reynaud JM; Gourru-Lesimple G; Perron H; Marche PN; Horvat B
Front Immunol; 2018; 9():2803. PubMed ID: 30574140
[TBL] [Abstract][Full Text] [Related]
43. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.
González-Oria MC; Márquez-Coello M; Girón-Ortega JA; Argente J; Moya M; Girón-González JA
J Neuroimmune Pharmacol; 2019 Sep; 14(3):413-422. PubMed ID: 30649665
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D receptor upregulation in alloreactive human T cells.
Joseph RW; Bayraktar UD; Kim TK; St John LS; Popat U; Khalili J; Molldrem JJ; Wieder ED; Komanduri KV
Hum Immunol; 2012 Jul; 73(7):693-8. PubMed ID: 22548720
[TBL] [Abstract][Full Text] [Related]
45. Different interleukin-17-secreting Toll-like receptor
Ferreira TB; Hygino J; Wing AC; Kasahara TM; Sacramento PM; Camargo S; Rueda F; Alves-Leon SV; Alvarenga R; Vasconcelos CC; Agrawal A; Gupta S; Bento CAM
Immunology; 2018 Jun; 154(2):239-252. PubMed ID: 29168181
[TBL] [Abstract][Full Text] [Related]
46. GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.
Peelen E; Muris AH; Damoiseaux J; Knippenberg S; Broens K; Smolders J; Cohen Tervaert JW; Hupperts R; Thewissen M
J Neuroimmunol; 2015 Mar; 280():36-42. PubMed ID: 25773153
[TBL] [Abstract][Full Text] [Related]
47. Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis .
Zeitelhofer M; Adzemovic MZ; Gomez-Cabrero D; Bergman P; Hochmeister S; N'diaye M; Paulson A; Ruhrmann S; Almgren M; Tegnér JN; Ekström TJ; Guerreiro-Cacais AO; Jagodic M
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1678-E1687. PubMed ID: 28196884
[TBL] [Abstract][Full Text] [Related]
48. Immune regulatory effects of high dose vitamin D
Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
[TBL] [Abstract][Full Text] [Related]
49. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D Supplementation Modulates ICOS+ and ICOS- Regulatory T Cell in Siblings of Children With Type 1 Diabetes.
Savastio S; Cadario F; D'Alfonso S; Stracuzzi M; Pozzi E; Raviolo S; Rizzollo S; Gigliotti L; Boggio E; Bellomo G; Basagni C; Bona G; Rabbone I; Dianzani U; Prodam F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32844222
[TBL] [Abstract][Full Text] [Related]
51. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis.
Martinez-Forero I; Garcia-Munoz R; Martinez-Pasamar S; Inoges S; Lopez-Diaz de Cerio A; Palacios R; Sepulcre J; Moreno B; Gonzalez Z; Fernandez-Diez B; Melero I; Bendandi M; Villoslada P
Eur J Immunol; 2008 Feb; 38(2):576-86. PubMed ID: 18200504
[TBL] [Abstract][Full Text] [Related]
52. Abnormal Tr1 differentiation in multiple sclerosis.
Astier AL; Hafler DA
J Neuroimmunol; 2007 Nov; 191(1-2):70-8. PubMed ID: 17936368
[TBL] [Abstract][Full Text] [Related]
53. The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)
Lu M; McComish BJ; Burdon KP; Taylor BV; Körner H
Front Immunol; 2019; 10():488. PubMed ID: 30941131
[TBL] [Abstract][Full Text] [Related]
54. Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.
Chiarini M; Serana F; Zanotti C; Capra R; Rasia S; Rottoli M; Rovaris M; Caputo D; Cavaletti G; Frigo M; Frigeni B; Clerici R; Rezzonico M; Caimi L; Imberti L
Mult Scler; 2012 Jun; 18(6):788-98. PubMed ID: 22086901
[TBL] [Abstract][Full Text] [Related]
55. Vitamin D, multiple sclerosis and inflammatory bowel disease.
Cantorna MT
Arch Biochem Biophys; 2012 Jul; 523(1):103-6. PubMed ID: 22085500
[TBL] [Abstract][Full Text] [Related]
56. IFN-α and CD46 stimulation are associated with active lupus and skew natural T regulatory cell differentiation to type 1 regulatory T (Tr1) cells.
Le Buanec H; Gougeon ML; Mathian A; Lebon P; Dupont JM; Peltre G; Hemon P; Schmid M; Bizzini B; Künding T; Burny A; Bensussan A; Amoura Z; Gallo RC; Zagury D
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):18995-9000. PubMed ID: 22065791
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D and multiple sclerosis: review of a possible association.
Summerday NM; Brown SJ; Allington DR; Rivey MP
J Pharm Pract; 2012 Feb; 25(1):75-84. PubMed ID: 21987526
[TBL] [Abstract][Full Text] [Related]
58. Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Haas J; Schwarz A; Korporal-Kuhnke M; Faller S; Jarius S; Wildemann B
J Neuroimmunol; 2016 May; 294():18-26. PubMed ID: 27138094
[TBL] [Abstract][Full Text] [Related]
59. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D
Liu W; Li H; Hao Y; Li Y; Lv M; Xue F; Liu X; Zhang L; Yang R
Mol Immunol; 2016 Oct; 78():89-97. PubMed ID: 27614264
[TBL] [Abstract][Full Text] [Related]
60. Immunomodulatory Effects of 1,25-Dihydroxyvitamin D
Lee WP; Willekens B; Cras P; Goossens H; Martínez-Cáceres E; Berneman ZN; Cools N
J Immunol Res; 2016; 2016():5392623. PubMed ID: 27703987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
